Ultromics pioneers precision heart failure detection. Our groundbreaking platform, EchoGo®, is revolutionizing the diagnosis of heart failure using artificial intelligence and cardiac ultrasound. Our technology empowers clinicians to make precise, efficient, and accurate assessments, drawing from the largest known heart disease dataset in echocardiography. We target challenging cardiac diseases, starting with HFpEF, to support timely diagnosis and early intervention. In collaboration with the Mayo Clinic, Johnson & Johnson, and Pfizer, we are continuously developing innovative diagnostic tools aimed at halting the progression of heart failure.
Learn more: https://www.ultromics.com/.
Follow Ultromics on social media for the latest news, X: https://x.com/ultromics, LinkedIn: https://www.linkedin.com/company/ultromics/.
Company Details
- Employees
- 71
- Founded
- -
- Address
- Oxford, Oxfordshire Ox1 1jd, Gb
- in****@****ics.com
- Industry
- Hospitals And Health Care
- NAICS
-
Health Care and Social AssistanceSocial Assistance
- Website
- ultromics.com
- Keywords
- Artificial Intelligence, Machine Learning, Healthcare, Cardiovascular Diagnosis, Diagnostic Tools, Medical Device, Medical Imaging.
- HQ
- Oxford, Oxfordshire
Ultromics Questions
Ultromics's website is ultromics.com
Ultromics's LinkedIn profile is https://uk.linkedin.com/company/ultromics
Ultromics has
71 employees.
View email and phone details for 71
employees at Ultromics.
Ultromics's industry is
Hospitals and Health Care
Ultromics's top competitors are
Brainomix,
Viz.ai,
Heartflow,
Refeyn,
Rapidai,
Pfizer,
Mirada Medical,
Caristo Diagnostics,
Perspectum Ltd,
Optellum.
Ultromics's support email address is info@ultromics.com
Ultromics's categories are Hospitals and Health Care
Ultromics's founding year is 2017
